Despite reports to the contrary, there is currently no scientific evidence to confirm that NSAIDs can worsen symptoms of COVID-19, say the US FDA and EMA.^[@CR1],[@CR2]^

NSAIDs, such as ibuprofen, are widely available by prescription or over-the-counter for the treatment of pain, and in some countries for the treatment of fever.

However, both agencies have become aware of news reports (particularly on social media) indicating that NSAIDs (including ibuprofen) could worsen COVID-19 symptoms.

Specifically, the USA FDA stated that a recent letter published in *The Lancet* \"*hypothesized that an enzyme (a molecule that aids a biochemical reaction in the body) is increased by NSAIDs and could aggravate COVID-19 symptoms*\".^[@CR1]^

In addition, the EMA mentioned that its Pharmacovigilance Risk Assessment Committee (PRAC) initiated a review in May 2019 of two NSAIDs (ibuprofen and ketoprofen) in response to a survey conducted \"*by the French National Agency for Medicines and Health Products Safety (ANSM) which suggested that infection due to chickenpox (varicella) and some bacterial infections could be made worse by these medicines*\".^[@CR2]^

Further to the above-mentioned PRAC safety review, the EMA highlighted \"*the need for epidemiological studies to be conducted in a timely manner to provide adequate evidence on any effect of NSAIDs on disease prognosis for COVID-19*\". The agency added that it \"*is reaching out to its stakeholders and is ready to actively support such studies, which could be useful in guiding any future treatment recommendations*\".

Both agencies recommend patients with any concerns regarding the NSAIDs they are taking (especially for chronic diseases) should speak to their doctor or pharmacist.^[@CR1],[@CR2]^ Patients should continue to use their NSAIDs as directed by their healthcare professional and in accordance with labelling instructions. Both the FDA and EMA are investigating this issue and will publicly communicate any further information as it becomes available.
